G
Giovanni B. Frisoni
Researcher at University of Geneva
Publications - 956
Citations - 55940
Giovanni B. Frisoni is an academic researcher from University of Geneva. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 101, co-authored 871 publications receiving 46199 citations. Previous affiliations of Giovanni B. Frisoni include Geneva College & University of Rome Tor Vergata.
Papers
More filters
Journal ArticleDOI
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study.
Niels Kruse,Staffan Persson,Daniel Alcolea,Justyna M.C. Bahl,Inês Baldeiras,Elisabetta Capello,Davide Chiasserini,Luisella Bocchio Chiavetto,Andreja Emeršič,Sebastiaan Engelborghs,Erden Eren,Tormod Fladby,Giovanni B. Frisoni,María Salud García-Ayllón,Sermin Genc,Olymbia Gkatzima,Niels H. H. Heegaard,Niels H. H. Heegaard,André Janeiro,Branislav Kovacech,H. Bea Kuiperij,Maria João Leitão,Alberto Lleó,Madalena Martins,Mafalda Matos,Hanne M. Møllergård,Flavio Nobili,Annika Öhrfelt,Lucilla Parnetti,Catarina R. Oliveira,Uroš Rot,Javier Sáez-Valero,Hanne Struyfs,Julia T. Tanassi,Peggy Taylor,Magda Tsolaki,Eugeen Vanmechelen,Marcel M. Verbeek,Norbert Zilka,Kaj Blennow,Henrik Zetterberg,Henrik Zetterberg,Brit Mollenhauer +42 more
TL;DR: This study showed that although factors such as preanalytical sample handling and lot-to-lot variability were minimized by the study design, high variation in absolute values of CSF aSyn was identified even when the same samples and same lots of assays were applied.
Journal ArticleDOI
Usefulness of Simple Measures of Temporal Lobe Atrophy in Probable Alzheimer's Disease
Giovanni B. Frisoni,Alberto Beltramello,Claudia Weiss,Cristina Geroldi,Angelo Bianchetti,Marco Trabucchi +5 more
TL;DR: Measurements of hippocampal atrophy were the most sensitive in the differentiation of cases from controls, and among them width of the temporal horn yielded the highest sensitivity, predicting the disease in 73% of cases with 95% specificity.
Journal ArticleDOI
AMYPAD Diagnostic and Patient Management Study: Rationale and design
Giovanni B. Frisoni,Frederik Barkhof,Daniele Altomare,Johannes Berkhof,Marina Boccardi,Elisa Canzoneri,Lyduine Collij,Alexander Drzezga,Gill Farrar,Valentina Garibotto,Rossella Gismondi,Juan-Domingo Gispert,Frank Jessen,Frank Jessen,Miia Kivipelto,Isadora Lopes Alves,José Luis Molinuevo,Agneta Nordberg,Agneta Nordberg,Pierre Payoux,Craig W. Ritchie,Irina Savicheva,Philip Scheltens,Mark E. Schmidt,Jonathan M. Schott,Andrew W. Stephens,Bart N.M. van Berckel,Bruno Vellas,Zuzana Walker,Zuzana Walker,Nicola Raffa +30 more
TL;DR: The Amyloid Imaging to Prevent Alzheimer's Disease–Diagnostic and Patient Management Study (AMYPAD‐DPMS) is designed to fill the gap in reimbursement of amyloid–positron emission tomography.
Journal ArticleDOI
Volumetric Differences in Mapped Hippocampal Regions Correlate with Increase of High Alpha Rhythm in Alzheimer's Disease
Davide V. Moretti,Annapaola Prestia,Claudia Fracassi,Cristina Geroldi,G. Binetti,Paolo Maria Rossini,Orazio Zanetti,Giovanni B. Frisoni +7 more
TL;DR: Results show that the increase of alpha3/alpha2 power ratio is correlated with atrophy of mapped hippocampal regions in Alzheimer's disease, which confirms the possible diagnostic role of EEG markers.
Journal ArticleDOI
Treatment of Alzheimer's disease with acetylcholinesterase inhibitors: bridging the gap between evidence and practice
TL;DR: The effect on behavioral symptoms, severe Alzheimer's dementia, and non-Alzheimer's forms of degenerative dementia need to be clarified as well as the modulating effect of frequently associated conditions such as cognitive changes due to physical diseases and cerebrovascular disease.